Tharman: S'pore will continue to invest in biomedical sector

Singapore

SINGAPORE will continue to invest to stay at the forefront of the biomedical sciences industry, even as the sector generated output of S$21.5 billion last year and employed 16,800 people, said Deputy Prime Minister Tharman Shanmugaratnam.

He made the point on Wednesday at a ground-breaking ceremony where drugmaker GlaxoSmithKline (GSK) said that it would set up a new global headquarters for Asia in Singapore, as it looks to the emerging markets to grow its business.

Seven of the top 10 global drug companies have established regional headquarters here and together, they provide diverse career opportunities and pathways for Singap…